News and Announcements
OncoSil Medical Recruits Second Subject at Monash Health Melbourne for Global Pancreatic Clinical Study Programme
- Published May 11, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
OncoSil Medical Limited (ASX: OSL) a medical device company focused on localised treatments for patients with pancreatic and liver cancer, is pleased to announce that Monash Health has recruited the second subject for its global clinical study program in pancreatic cancer. The second subject has completed all baseline assessments, and will now commence one month of chemotherapy prior to implantation with the OncoSil™ device.
KEY TAKEAWAYS:
- Secondsubjectrecruited for global clinical study in pancreatic cancer by MonashHealth, Melbourne
- This subject is the second in a total of 20 subjects required to meet the Supplemental data request to secure CE Marking
- First subject implanted with the OncoSil™ device on April 24 at Monash Health, Melbourne
OncoSil Chief Medical Officer Dr Ashish Soman commented: “We are pleased with the recruitment efforts and engagement to date by MonashHealth as our lead Australian trial site, and continue to work closely with their team to progress additional patient recruitment for this important global study.”
OncoSil Medical is a medical device company seeking to advance radiation for cancer patients.
Company Updates
The asset class where the market has no vote
Litigation funding returns are decided in a courtroom, not a cycle. Knightsbridge’s Head of Capital is careful to call that a different risk rather than a lower one, and his answer to it is spread, not concentration. Most alternative assets still answer to something. Property answers to rates. Private credit answers to defaults. Even the […]
The listing fee vendors pay whether the house sells or not
Australia’s property portals collect more than $2 billion a year while national listings sit flat. An Australian-built AI platform is targeting the economics, not just the interface. An Australian vendor listing a home pays a vendor-paid advertising fee on top of agency commission. Rama Dwarapudi, Founder and Chief Executive Officer of RealSearch, puts a typical […]
Reinventing the Condom: How an Australian Deep-Tech Startup Plans to Disrupt a $12 Billion Market
For more than half a century, the global condom industry has remained fundamentally unchanged, constrained by standard materials like latex and solid synthetic polymers. Despite widespread consumer demand for better alternatives, product design has treated the device strictly as a mechanical barrier, sacrificing feel for function. Sydney-based Eudaemon Technologies is setting out to upend that […]
Backed By Leading Investment Groups and Family Offices
